Showing results (91-100 of 168) with videos related to
Sort By:
Pageof 17
Intervirology|June 12, 2004
A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral loadNamiki Izumi, Yasuhiro Asahina, Masayuki Kurosaki, et al.Biochemical and Biophysical Research Communications|October 5, 2020
SPOCK1 induces adipose tissue maturation: New insights into the function of SPOCK1 in metabolismRehab Alshargabi, Takanori Shinjo, Misaki Iwashita, et al.Bioscience Trends|February 21, 2022
Analysis of microsatellite instability using Promega panel in dermatofibrosarcoma protuberansSaki Maeda-Otsuka, Myangat Tselmeg Mijiddorj, Ikko Kajihara, et al.Journal of Hepatology|August 21, 2003
Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimensYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.Scientific Reports|August 25, 2024
MgO-enhanced β-TCP promotes osteogenesis in both in vitro and in vivo rat modelsKenichiro Saito, Yusuke Inagaki, Yoshinobu Uchihara, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2005
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patientsMasayuki Kurosaki, Namiki Izumi, Yuko Onuki, et al.Journal of Hepatology|December 4, 2003
Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype CYasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.Intervirology|March 24, 2005
Development of hepatocellular carcinoma after interferon therapy in chronic hepatitis C. Is it possible to reduce the incidence by ribanirin and IFN combination therapy?Namiki Izumi, Asahina Yasuhiro, Masayuki Kurosaki, et al.Drug Discoveries & Therapeutics|February 27, 2023
A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapySaori Yamada-Kanazawa, Shuichi Shimada, Wakana Nakayama, et al.Intervirology|July 19, 2005
Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis BHiroyuki Nakanishi, Masayuki Kurosaki, Yasuhiro Asahina, et al.Pageof 17